Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Gencydo nasal spray on early nasal response after allergen exposure in grass pollen allergy
DRKS00004312Phase 2Completed
- Sponsor
- University Hospital Freiburg
- Start
- Oct 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of Citrus + Cydonia comp in allergic rhinitis (AR) (2 arms), sponsored by University Hospital Freiburg. Primary endpoint: Early nasal response after allergen exposure. Started Oct 2012; status: completed.
02
Drugs
Citrus + Cydonia comp.
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on DRKS00004312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004312.